cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Precision Biosciences Inc
12 own
16 watching
Current Price
$16
$2.71
(20.39%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
41.47M
52-Week High
52-Week High
36.15000
52-Week Low
52-Week Low
8.25000
Average Volume
Average Volume
0.17M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization41.47M
icon52-Week High36.15000
icon52-Week Low8.25000
iconAverage Volume0.17M
iconDividend Yield--
iconP/E Ratio--
What does the Precision Biosciences Inc do?
Precision BioSciences, Inc., a clinical stage gene editing company, develops vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. The company operates through two segments, Therapeutic and Food. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which a specific type of immune cell, called a T cell, is genetically engineered to recognize and kill cancer cells; PBCAR0191, which is in Phase 1/2a clinical trial in adult patients with R/R NHL or R/R B-cell precursor acute lymphoblastic leukemia, or B-ALL; PBCAR19B, an anti-CD19 CAR T candidate built on the stealth cell platform utilizing a single-step gene edit to minimize the risk of chromosome abnormalities; and PBCAR269A, an investigational allogeneic CAR T immunotherapy targeting BCMA for the treatment of R/R multiple myeloma. The company has development and commercial license agreement with Servier to develop allogeneic chimeric antigen receptor T cell therapies for antigen targets, hematological cancer targets beyond CD19, and solid tumor targets; Tiziana Life Sciences to evaluate foralumab, a fully human anti-CD3 monoclonal antibody as a lymphodepleting agent for the potential treatment of cancers; and iECURE, Inc. to develop ARCUS-based gene editing therapies. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.
Read More
How much money does Precision Biosciences Inc make?
News & Events about Precision Biosciences Inc.
Ticker Report
11 months ago
Precision BioSciences (NASDAQ:DTIL Get Rating) and Brainstorm Cell Therapeutics (NASDAQ:BCLI Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, risk, ...
Benzinga
11 months ago
read more...
Business Wire
1 year ago
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced a promotion and organizational changes within the Companys Senior Leadership Team (SLT). The company announced the...
Business Wire
1 year ago
Precision BioSciences (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today reported on its significant accomplishments in 2022 and announced its corporate priorities and anticipated clinical development and...
Business Wire
1 year ago
Precision BioSciences (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced that the U.S. Food and Drug Administration (FDA) provided supportive Type C feedback on the Companys CMC processes and...
Frequently Asked Questions
Frequently Asked Questions
What is Precision Biosciences Inc share price today?
plus_minus_icon
Can Indians buy Precision Biosciences Inc shares?
plus_minus_icon
How can I buy Precision Biosciences Inc shares from India?
plus_minus_icon
Can Fractional shares of Precision Biosciences Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Precision Biosciences Inc stocks?
plus_minus_icon
What is today’s traded volume of Precision Biosciences Inc?
plus_minus_icon
What is today’s market capitalisation of Precision Biosciences Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Precision Biosciences Inc?
plus_minus_icon
What percentage is Precision Biosciences Inc down from its 52-Week High?
plus_minus_icon
What percentage is Precision Biosciences Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$16
$2.71
(20.39%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00